Credit Suisse Starts Diplomat Pharmacy (DPLO) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures rise on tech buying, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices jump after Trump threatens to hit Iran 'very hard'
- Oracle reports earnings today: Analysts say this metric could 'catalyze higher multiples'
- UBS sees generational semiconductor boom, highlights stock winners
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
Wells Fargo Starts Diplomat Pharmacy (DPLO) at Market Perform
November 19, 2014 8:50 AM ESTWells Fargo initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with a Market Perform rating and a price target of $24-$26.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreWilliam Blair Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:35 AM ESTWilliam Blair initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreJPMorgan Starts Diplomat Pharmacy (DPLO) at Overweight
November 19, 2014 7:29 AM ESTJPMorgan initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Overweight rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreLeerink Swann Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:28 AM ESTLeerink Swann initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... More